SpyGlass Pharma, Inc. (SGP)

NASDAQ: SGP · Real-Time Price · USD

21.62

+0.80 (3.84%)

Jul 28, 2026, 4:00 PM EDT - Market closed

SpyGlass Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Cap	723	-	-	-
Market Cap Growth	-	-	-	-
Enterprise Value	473.43	0	0	0

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.01	-0.02	-0.06	0
Net Debt / Equity Ratio	-1.00	1.07	0.21	1.22
Net Debt / EBITDA Ratio	-	2.59	0.46	2.86
Net Debt / FCF Ratio	-	3.16	0.52	3.23
Quick Ratio	37.75	12.57	2.14	25.46
Current Ratio	38.00	12.67	2.23	25.57
Return on Equity (ROE)	-	50.05%	278.91%	-33.67%
Return on Assets (ROA)	-	-59.56%	-83.96%	-34.58%
Return on Invested Capital (ROIC)	-	-616.25%	-785.76%	-2661.84%
Return on Capital Employed (ROCE)	-	-67.50%	-98.26%	-35.97%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Buyback Yield / Dilution	-	-23.98%	-2.89%	-
Total Shareholder Return	-	-23.98%	-2.89%	-

SEC Filings: 10-K · 10-Q